Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension.

Pérez-Peñate, Gregorio Miguel

Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension. [electronic resource] - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation Dec 2008 - 1326-32 p. digital

Publication Type: Journal Article

1557-3117

10.1016/j.healun.2008.08.007 doi


Administration, Inhalation
Adult
Aged
Anticoagulants--therapeutic use
Cyclic GMP--blood
Cyclic Nucleotide Phosphodiesterases, Type 5--metabolism
Diuretics--therapeutic use
Female
Follow-Up Studies
Humans
Hypertension, Pulmonary--complications
Male
Middle Aged
Nitric Oxide--administration & dosage
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors--therapeutic use
Safety
Thromboembolism--complications
Treatment Outcome
Vasodilator Agents--therapeutic use